Results 51 to 60 of about 557,485 (321)
Simple Summary Pituitary adenomas are highly prevalent intracranial neoplasms that can be locally invasive in up to half of cases. Consequently, using the term “PitNETs” (pituitary neuroendocrine tumors) instead of pituitary adenoma is recommended to ...
D. Țăpoi +4 more
semanticscholar +1 more source
Radiation-associated sarcoma of the skull base after irradiation for pituitary adenoma
Secondary, radiation-induced neoplasms represent a significant long-term risk after radiation treatment, and radiation-induced sarcomas (RAS) have an especially poor prognosis. These have rarely been reported after irradiation for pituitary adenomas.
Cara L. Sedney +4 more
doaj +1 more source
Granular cell tumors of the pituitary belong to a rare family of neoplasms, arising from the posterior pituitary gland. Although considered benign, they may cause significant morbidity and residual disease after resection can lead to poor clinical ...
Christopher S. Hong +7 more
doaj +1 more source
Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas.
Pituitary adenomas are neoplasms derived from the endocrine cells of the anterior pituitary gland. Most frequently, they are benign tumors, but may sometimes display an aggressive course, and in some cases metastasize. Their biology, including their wide
M. Ilie +3 more
semanticscholar +1 more source
The NETting of pituitary adenoma: a gland illusion
Disease classification, fundamental to accurately reflecting critical knowledge of disease causes and consequences, underpins clinical care, service planning, payments, safety, and quality.
Ken K. Y. Ho +4 more
semanticscholar +1 more source
Pituitary adenomas, monoclonal in origin, are the most common intracranial neoplasms. Altered gene expression as well as somatic mutations is detected frequently in pituitary adenomas.
Peng Zhao +7 more
doaj +1 more source
Multiple endocrine neoplasia syndrome type 1 (MEN1, Wermer's syndrome) is a group of heterogeneous inherited diseases, with its pathogenesis related to hyperplasia or neoplasms of several endocrine glands.
L. Ya. Rozhinskaya +7 more
doaj +1 more source
Targeted treatment with somatostatin analogues: widening horizons of clinical practice
Targeted treatment with somatostatin analogues (SA) in acromegaly and neuroendocrine neoplasms may have some benefits compared to curative treatments, because these agents decrease excessive hormone secretion and exert a tumor-suppressive effect ...
Vyacheslav S. Pronin +3 more
doaj +1 more source
Background: Pituitary adenomas represent the most common pituitary disorder, with an estimated prevalence as high as 20%, and they can manifest with hormone hypersecretion or deficiency, neurological symptoms from mass effect, or incidental findings on ...
Janez Ravnik +8 more
doaj +1 more source
MicroRNAs in Human Pituitary Adenomas
MicroRNAs (miRNAs) are a class of recently identified noncoding RNAs that regulate gene expression at posttranscriptional level. Due to the large number of genes regulated by miRNAs, miRNAs play important roles in many cellular processes.
Xu-Hui Li +4 more
doaj +1 more source

